[Leu37]-beta-Amyloid (1-42) features a hydrophobic substitution affecting aggregation propensity and β-sheet assembly. This variant enables detailed investigations of peptide oligomerization, membrane interactions, and amyloidogenesis. Its sequence supports high-resolution structural studies and aggregation kinetics research. Applications span biophysics, peptide design, and protein misfolding analysis.
CAT No: A13315
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More